6572.TWO PlexBio Co., Ltd.

Healthcare Medical Devices Taiwan OTC Exchange
6.08 TWD
Close of Nov 6, 2026
5.16 15.80
Market cap
TWD 630M
P/E
-
P/B
2.09x
ROE
-20.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6572.TWO undervalued?

Graham number

The Graham number of PlexBio Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PlexBio Co., Ltd. fundamental analysis

No fundamental analysis for PlexBio Co., Ltd. yet.

PlexBio Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PlexBio Co., Ltd.

PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It provides workflow navigation services; automated sample preparation kits; IntelliPlex platform that is designed for pCode technology with throughput sample-to-answer multiplexing assays; oncology assays, a portfolio for advanced molecular testing; and customized pCode assays. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.

Full company profile